Overview

Tranexamic Acid in Adherent Placenta (TAP)

Status:
Withdrawn

Trial end date:
2021-12-01

Target enrollment:

Participant gender:

Summary

The objective of this study is to investigate the effect of tranexamic acid (TXA) administration on the outcome of cesarean-hysterectomy in women with suspected Morbidly Adherent Placenta (MAP; placenta accreta, increta, percreta).

Phase:

Phase 3

Details

Lead Sponsor:

Baylor College of Medicine

Treatments:

Tranexamic Acid